A 58-year-old man from Delhi presents with fatigue and mild jaundice for 2 weeks. He has a history of chronic kidney disease (eGFR 28 mL/min/1.73m²) and is not on erythropoietin-stimulating agents. On examination, he appears pale. Laboratory findings: Hb 8.5 g/dL, MCV 82 fL, reticulocyte count 0.8%, serum creatinine 2.8 mg/dL, serum bilirubin 2.2 mg/dL (indirect 1.8 mg/dL), LDH 320 U/L, haptoglobin 18 mg/dL (normal >30). Peripheral smear shows schistocytes and polychromasia. What is the most likely diagnosis?

Explanation

## Clinical Diagnosis: Uremic Thrombotic Microangiopathy (TMA) **Key Point:** The combination of **schistocytes on smear, low haptoglobin, elevated LDH, indirect hyperbilirubinemia, and advanced CKD** indicates **microangiopathic hemolytic anemia (MAHA)** due to uremic thrombotic microangiopathy. ### Diagnostic Framework for Hemolysis | Parameter | Finding | Interpretation | |-----------|---------|----------------| | **Hemoglobin** | 8.5 g/dL | Anemia present | | **MCV** | 82 fL | Normocytic (typical of hemolysis) | | **Reticulocyte count** | 0.8% | **LOW for degree of anemia** — inadequate bone marrow response | | **Schistocytes** | Present | Mechanical fragmentation of RBCs in microvasculature | | **Haptoglobin** | 18 mg/dL (low) | Consumed by free Hb binding; hallmark of intravascular hemolysis | | **LDH** | 320 U/L (elevated) | Released from lysed RBCs | | **Indirect bilirubin** | 1.8 mg/dL (elevated) | Heme catabolism from RBC breakdown | | **eGFR** | 28 mL/min/1.73m² | Stage 4 CKD; uremic toxins accumulate | ### Pathophysiology of Uremic TMA 1. **Uremic toxins** accumulate in advanced CKD (eGFR <30). 2. **Endothelial damage** in renal and systemic microvasculature. 3. **Platelet aggregation** and fibrin deposition in small vessels. 4. **Mechanical fragmentation** of RBCs passing through fibrin strands → schistocytes. 5. **Intravascular hemolysis** → low haptoglobin, elevated LDH, elevated indirect bilirubin. **High-Yield:** **Schistocytes on smear = mechanical hemolysis.** In the context of advanced CKD without dialysis, uremic TMA is the most likely cause. **Clinical Pearl:** The **inappropriately low reticulocyte count (0.8%)** in the presence of hemolysis suggests either: - Uremic suppression of erythropoiesis, OR - Concurrent bone marrow dysfunction. This is typical of uremic hemolysis and distinguishes it from immune hemolytic anemia (which usually has a brisk reticulocytosis >3%). ### Mermaid: Diagnostic Algorithm for Hemolytic Anemia in CKD ```mermaid flowchart TD A[Anemia + Jaundice + CKD]:::outcome --> B{Schistocytes on smear?}:::decision B -->|Yes| C{eGFR < 30?}:::decision B -->|No| D[Consider immune hemolysis<br/>or other etiology] C -->|Yes| E[Uremic TMA]:::action C -->|No| F[Consider HUS, TTP,<br/>DIC, prosthetic valve] E --> G[Start dialysis,<br/>manage CKD]:::action ``` ### Why This Is Not the Other Options - **Simple anemia of CKD** would NOT produce schistocytes, low haptoglobin, or elevated LDH. It is a normocytic anemia of chronic disease with a low reticulocyte count, but WITHOUT hemolysis markers. - **Immune hemolytic anemia** would typically have a **brisk reticulocytosis (>3%)**, a positive direct Coombs test, and usually no schistocytes. The low reticulocyte count here argues against immune hemolysis. - **Aplastic anemia** would present with pancytopenia (low WBC, low platelets) and a low reticulocyte count, but would NOT have schistocytes, low haptoglobin, or elevated LDH.